Mapsi Photonics
Mapsi Photonics was founded in 2021 with the goal of manufacturing next-gen silicon-based infrared sensors.
High tech venture investors
Mapsi Photonics was founded in 2021 with the goal of manufacturing next-gen silicon-based infrared sensors.
Deep Detection was founded in 2020 with the goal of developing next-gen multispectral X-ray cameras for material detection and characterization
AGPhotonics was founded in 2023 with the goal of desigining and manufacturing next-gen photonic integrated devices
Bitsphi Diagnosis was established in 2021, with the goal of developing mathematical models that could be applied to the diagnosis of cognitive conditions such as ADHD.
Bioherent was established in 2021 as a spin-off stemming from the University of Málaga, with the goal of creating a photonic biosensor for IVD diagnosis of drug allergy.
Established in 2018, Sphere Ultrafast Photonics offers state-of-the-art products and services in the ultrafast pulsed laser regime. Using proprietary technology, their devices and carry out simulatenous measurement and compression of the most demanding laser pulses in order to deliver the best performance out of your laser systems.
Based in Valencia, FYLA provides fiber lasers, ultrafast pulsed lasers and accessory modules for several high-end industrial applications. FYLA is the only company in the South of Europe, and one of the few in the world, able to produce and control the supply and manufacturing of 100% of the components and technologies required for the production of their lasers.
Established in 2015, 2eyesVision has developed the SimVis, an innovative medical device that allows the simulation of intraocular or contact lenses for patients affected by presbyopia or cataracts.
Private company launched in Madrid, specialising in autopilots for Unmanned Aerial Vehicles (UAV), as well as all associated hardware and software for full Flight Control Systems.
Nuclear imaging company, founded in 2003 as a spin-off from the Corpuscular Physics Institute of CSIC. The company develops innovative devices for cancer diagnosis and treatment, as well as early Alzheimer detection. In November 2016, Bruker acquired, Oncovision’s preclinical product line, Albira, a multimodal imaging device for preclinical research.
Founded in 2003, the company was a spin-off from the University of Porto founded by a team with more than fifteen years of experience in the field. The company specialized in the development of fiberoptic sources, fiber sensing systems and OEM modules.